Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MCM, LabCorp Expand Access to Global Central Lab Services | Contract Pharma
Breaking News

MCM, LabCorp Expand Access to Global Central Lab Services

To extend service offerings to clients in Japan and globally

Mitsubishi Chemical Medience Corp. (MCM) has signed a Master Service Agreement with the clinical trials division of Laboratory Corporation of America that allows LabCorp Clinical Trials and MCM to extend their service offerings to clients in Japan and around the world, respectfully.
 
“Pharmaceutical sponsors everywhere continue to look to new markets and technologies for drug development opportunities, and our clients are no different,” said Mr. Shinichi Yoshihara, president and chief executive officer of Mitsubishi Chemical Medience Corp. “We are therefore excited to work closely with LabCorp as a global leader in central lab, biomarker and specialty testing, and with cutting-edge technologies from both sides we are confident this partnership will provide new channels of growth and competitive advantage for both companies.”
 
“MCM is a leading diagnostic laboratory and central lab in Japan with considerable experience and long-standing relationships in the medical and pharmaceutical communities,” said Dr. Mark Brecher, LabCorp’s chief medical officer. “The two companies complement each other in this respect, and we look forward to working together to offer a complete global solution for our customers conducting trials in Japan and around the globe.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters